课题基金 / 基金详情

Task X19: Development of Assays and Reagents for Zika Virus Vaccines

Task X19: Development of Assays and Reagents for Zika Virus Vaccines
任务 X19：寨卡病毒疫苗检测方法和试剂的开发
批准号：
9915594
负责人：
RANDI HORNBACK
金额：
$110.53万
依托单位：
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
项目状态：
已结题
起止时间：
2016-08-31 至 2020-01-31
来源：
https://reporter.nih.gov/project-details/9915594
关键词：
BiologicalClinicalCommunicable DiseasesContractsDevelopmentFeasibility StudiesPhaseReagentSamplingServicesTestingToxicity TestsVaccinesZika virus vaccineassay developmentefficacy testingevaluation/testingimmunogenicitynovel vaccinesproduct developmentsafety testingtesting services

项目摘要

项目成果

RANDI HORNBACK的其他基金

相似基金

相关文献

中文摘要
翻译
传染病疫苗和其他生物制剂的评估和测试服务（ETS）合同提供了从早期可行性研究到I/II期材料生产的各种产品开发服务，包括检测开发;免疫原性和有效性测试;临床和非临床样品测试;以及安全性和毒性测试。 这些服务将促进开发和引进新的疫苗和生物制剂，以防治各种传染病。
英文摘要
The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against a wide array of infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies
Task X21: Preparedness for Testing NIAID Priority Vaccines in General Safety and Toxicology Studies
TASK X23: Control Animal Meta-Analysis for Ebola and Other Filoviruses
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data